Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kazia calls for greater awareness of the most lethal women's disease in Australia 2019-05-08 09:55
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference 2019-04-01 11:29
Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting 2019-03-25 13:25
Kazia Share Purchase Plan Raises A$0.8 Million, Taking Total Funds Raised to A$4.2 Million 2018-11-20 12:53
Progress Update on GDC-0084 Program 2018-10-29 18:00
Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer 2018-10-22 18:00
Kazia Raises A$3.4 Million to Progress R&D Programs 2018-10-18 09:21
Cantrixil Phase I Study Progresses To Next Stage 2018-10-10 15:15
Kazia Releases Preliminary Cantrixil Phase I Data 2018-06-19 18:00
Commencement Of Phase II Clinical Study Of GDC-0084 2018-03-29 08:33
Kazia Receives FDA Orphan Designation for GDC-0084 2018-02-23 17:20
1 2 3 4